Stay updated on Padsevonil for Drug-Resistant Epilepsy Clinical Trial
Sign up to get notified when there's something new on the Padsevonil for Drug-Resistant Epilepsy Clinical Trial page.

Latest updates to the Padsevonil for Drug-Resistant Epilepsy Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.3.4 was added and v3.3.3 was removed from the Study Documents section.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedDifference1.0%

- Check47 days agoChange DetectedThe change consists of a minor revision label update (Revision: v3.3.2 added, Revision: v3.3.1 removed); no study content or functionality was altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check55 days agoChange DetectedPublication section wording updated to indicate that results publications are provided voluntarily by the person entering the information. The revision label changed from v3.2.0 to v3.3.1.SummaryDifference0.0%

- Check62 days agoChange DetectedA general notice about government funding lapse and NIH operating status was removed from the page.SummaryDifference0.2%

- Check76 days agoChange DetectedOnly UI and styling tweaks are visible in the new screenshot. Core study data such as status, outcomes, enrollment, and eligibility criteria appear unchanged.SummaryDifference0.2%

Stay in the know with updates to Padsevonil for Drug-Resistant Epilepsy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Padsevonil for Drug-Resistant Epilepsy Clinical Trial page.